Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The muscle stem cell case of Benjamin Button: rejuvenating muscle regenerative capacity through nutraceuticals
Taylor Peach, Mattia Quattrocelli
Taylor Peach, Mattia Quattrocelli
View: Text | PDF
Commentary

The muscle stem cell case of Benjamin Button: rejuvenating muscle regenerative capacity through nutraceuticals

  • Text
  • PDF
Abstract

Aging negatively affects the capacity of muscle stem cells (MuSCs) to regenerate muscle. In this issue of the JCI, Ancel, Michaud, and colleagues used a high-content imaging screen to identify nicotinamide and pyridoxine as promoters of MuSC function. The combination of the two compounds promoted MuSC function in vivo in aged mice and in primary cells isolated from older individuals. Furthermore, the two compounds were lower in the circulation of older men, paralleling decreases in lean mass and gait speed. These results advance the translational perspective of rejuvenating MuSC function through nutraceuticals.

Authors

Taylor Peach, Mattia Quattrocelli

×

Figure 1

Nicotinamide and pyridoxine converge to rejuvenate aging MuSCs.

Options: View larger image (or click on image) Download as PowerPoint
Nicotinamide and pyridoxine converge to rejuvenate aging MuSCs.
Ancel et...
Ancel et al. (3) used mouse models, human myogenic progenitor cells, and data from the Bushehr Elderly Health cohort to demonstrate the involvement of nicotinamide and pyridoxine with MuSCs. The two nutraceuticals enhanced the regenerative capacity in aging muscle through parallel pathways: nicotinamide stimulated MuSC proliferation via CK1α inhibition, thereby promoting β-catenin transcriptional outputs, and pyridoxine promoted AKT phosphorylation to enhance MuSC differentiation. In aged mice, the treatment combination rescued muscle repair.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts